Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioRestorative Therapies Inc BRTX

BioRestorative Therapies, Inc. is engaged in developing therapeutic products using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells... see more

Recent & Breaking News (NDAQ:BRTX)

BioRestorative Therapies Receives Patent in Israel For Its Metabolic Program

GlobeNewswire December 12, 2019

BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program

GlobeNewswire October 23, 2019

BioRestorative Therapies Scientific Advisory Board Member and Clinical Director of Regenerative Disc/Spine Program, Dr. Wayne J. Olan, to Receive Prestigious Award

GlobeNewswire September 16, 2019

BioRestorative Therapies Comments on Recent Promotional Activity

GlobeNewswire September 13, 2019

BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome

GlobeNewswire September 11, 2019

BioRestorative Therapies' Stockholders Approve Institutional Investor Agreement and Exchange Agreements

GlobeNewswire September 5, 2019

BioRestorative Therapies Signs $5.4 Million Financing with Institutional Investor

GlobeNewswire July 31, 2019

BioRestorative Therapies to Present at the 22nd Annual American Society of Gene and Cell Therapy as to Data on its Platform Technology for the Treatment of Metabolic Disorders

GlobeNewswire April 29, 2019

BioRestorative Therapies Announces the Creation of a Disc Advisory Committee

GlobeNewswire February 27, 2019

BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in the United States

GlobeNewswire November 15, 2018

BioRestorative Therapies Announces the Appointment of Lance Alstodt as Executive VP and Chief Strategy Officer

GlobeNewswire October 18, 2018

BioRestorative Therapies Announces Metabolic Research Collaboration with University of Pennsylvania

GlobeNewswire September 24, 2018

BioRestorative Therapies Announces Publication of Study Results Validating the Benefits of Using Hypoxic Cultured Cells to Treat Patients with Degenerative Disc Disease

GlobeNewswire August 15, 2018

BioRestorative Therapies Appoints Jason M. Lipetz, M.D. to its Scientific Advisory Board

GlobeNewswire July 25, 2018

BioRestorative Therapies Reports Positive Findings from Independent Review of its BRTX-100 Program

GlobeNewswire June 11, 2018

BioRestorative Therapies Appoints Wayne J. Olan, M.D. as Clinical Director of Regenerative Disc/Spine Program

GlobeNewswire May 7, 2018

BioRestorative Therapies Announces the Appointment of Adam D. Bergstein as Sr. VP, Planning and Business Development

GlobeNewswire January 22, 2018

BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in Japan

GlobeNewswire October 17, 2017

BioRestorative Therapies Announces Published Study of Licensed Technology to Treat Lumbar Degenerative Disc Disease

GlobeNewswire October 5, 2017

BioRestorative Therapies to Present at 6th Annual Marcum MicroCap Conference

GlobeNewswire June 14, 2017